Q4 2024 · 13F-HR
Velan Capital Investment Management LPholdings as filed
Filed 2025-02-14 · accession 0001848809-25-000001
$115.9M
Reported value
45
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 471871202 | JSPR | JASPER THERAPEUTICS INC | $30.7M | 26.5% | 1,433,828 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $23.1M | 19.9% | 300,000 | Common | SOLE |
| 427746102 | HRTX | HERON THERAPEUTICS INC | $10.7M | 9.22% | 6,986,744 | Common | SOLE |
| 89157D105 | TRML | TOURMALINE BIO INC | $8.6M | 7.42% | 423,795 | Common | SOLE |
| 74365U107 | TARA | PROTARA THERAPEUTICS INC | $8.3M | 7.19% | 1,579,000 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $6.7M | 5.78% | 185,520 | Common | SOLE |
| 76200L309 | RZLT | REZOLUTE INC | $3.9M | 3.38% | 800,000 | Common | SOLE |
| 53635D202 | LQDA | LIQUIDIA CORPORATION | $3.5M | 3.04% | 300,000 | Common | SOLE |
| 488445206 | ZVRA | ZEVRA THERAPEUTICS INC | $2.5M | 2.16% | 300,000 | Common | SOLE |
| 45779A846 | NSPR | INSPIREMD INC | $2.4M | 2.05% | 904,029 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $2.3M | 2.00% | 50,000 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $2.2M | 1.90% | 181,367 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $1.8M | 1.59% | 97,889 | Common | SOLE |
| 46489V302 | CATX | PERSPECTIVE THERAPEUTICS INC | $1.6M | 1.38% | 500,000 | Common | SOLE |
| 28617K101 | ELDN | ELEDON PHARMACEUTICALS INC | $1.3M | 1.15% | 323,973 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $1.3M | 1.13% | 150,000 | Common | SOLE |
| 19459J104 | COLL | COLLEGIUM PHARMACEUTICAL INC | $821,825 | 0.71% | 28,685 | Common | SOLE |
| 05338F306 | AVTX | AVALO THERAPEUTICS INC | $817,092 | 0.71% | 109,972 | Common | SOLE |
| 21833P301 | CRBP | CORBUS PHARMACEUTICALS HLDGS | $669,060 | 0.58% | 56,700 | Common | SOLE |
| 88032L605 | TENX | TENAX THERAPEUTICS INC | $515,831 | 0.45% | 83,333 | Common | SOLE |
| 49721T507 | KPRX | KIORA PHARMACEUTICALS INC | $403,336 | 0.35% | 122,223 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $173,460 | 0.15% | 49,000 | Common | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $160,810 | 0.14% | 13,000 | Common | SOLE |
| 75915K309 | RGLS | REGULUS THERAPEUTICS INC | $110,600 | 0.10% | 70,000 | Common | SOLE |
| N71542109 | PRQR | PROQR THRAPEUTICS N V | $107,325 | 0.09% | 40,500 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $103,950 | 0.09% | 55,000 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $94,500 | 0.08% | 90,000 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $94,180 | 0.08% | 17,000 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $76,650 | 0.07% | 35,000 | Common | SOLE |
| 29251M106 | ENTA | ENANTA PHARMACEUTICALS INC | $74,750 | 0.06% | 13,000 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $69,660 | 0.06% | 18,000 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $67,845 | 0.06% | 75,000 | Common | SOLE |
| 00461U105 | ACRS | ACLARIS THERAPEUTICS INC | $66,960 | 0.06% | 27,000 | Common | SOLE |
| 690469101 | OVID | OVID THERAPEUTICS INC | $65,359 | 0.06% | 70,000 | Common | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $55,700 | 0.05% | 10,000 | Common | SOLE |
| 869367102 | — | SUTRO BIOPHARMA INC | $55,200 | 0.05% | 30,000 | Common | SOLE |
| 69353Y103 | PMVP | PMV PHARMACEUTICALS INC | $52,850 | 0.05% | 35,000 | Common | SOLE |
| 31572Q808 | FGENEUR | FIBROGEN INC | $42,360 | 0.04% | 80,000 | Common | SOLE |
| 23284F105 | CTMX | CYTOMX THERAPEUTICS INC | $36,050 | 0.03% | 35,000 | Common | SOLE |
| 50107A104 | KRON1USD | KRONOS BIO INC | $33,250 | 0.03% | 35,000 | Common | SOLE |
| 48576U106 | KPTIEUR | KARYOPHARM THERAPEUTICS INC | $27,052 | 0.02% | 40,000 | Common | SOLE |
| 097702104 | BOLT1EUR | BOLT BIOTHERAPEUTICS INC | $26,755 | 0.02% | 50,000 | Common | SOLE |
| 28623U101 | — | ELEVATION ONCOLOGY INC | $25,317 | 0.02% | 45,000 | Common | SOLE |
| 19188J409 | COCP | COCRYSTAL PHARMA INC | $20,200 | 0.02% | 10,000 | Common | SOLE |
| 65343E108 | NXTCEUR | NEXTCURE INC | $19,275 | 0.02% | 25,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.